Andrew Profile
Andrew

@SingletonNeuro

Followers
944
Following
635
Media
33
Statuses
409

Opinions are my own & do not rep NIA/NIH/HHS

Joined March 2018
Don't wanna be here? Send us removal request.
@SingletonNeuro
Andrew
2 years
RT @PaulaSaffieA: Great opportunity!!! @interneurona could you share it between your #LATAM colleagues???.
0
1
0
@SingletonNeuro
Andrew
2 years
Kimberley has done an amazing job standing up high throughput long read sequencing at CARD….
@nanopore
Oxford Nanopore
2 years
Today we heard from Kimberley on utilising long nanopore reads to sequence ~4,000 human brain clinical research samples, to further understand Alzheimer’s disease and related dementias #nanoporeconf
Tweet media one
0
0
9
@SingletonNeuro
Andrew
2 years
love this collaboration!.
@YokoyamaLabUCSF
Jennifer Yokoyama
2 years
Our own @C_WSolsberg @halsty and friends from NIH CARD 🧬 identify novel AD loci by leveraging diversity across populations @UCSFmac.
1
1
6
@SingletonNeuro
Andrew
2 years
RT @mike_nalls: Been a great day for publications from the team. @mkoretsky1 and the team great job on showing genetic overlap and in some….
0
6
0
@SingletonNeuro
Andrew
2 years
RT @mitenjain: Dramatic improvement for @nanopore DRS using kits RNA004 vs RNA002 @NUBioE1.a) Human poly-A RNA alignment identity: 2019 (RN….
0
34
0
@SingletonNeuro
Andrew
2 years
RT @mike_nalls: Pssst, next GP2 release in ~2 weeks 🤐. Release 5 for Cinco de Mayo (well a few days after).
0
3
0
@SingletonNeuro
Andrew
2 years
RT @mike_nalls: 41 novel targets, network insights and potential tox inferences . #opensource #openscience . app here .
0
2
0
@SingletonNeuro
Andrew
2 years
RT @mike_nalls: New preprint from the team at CARD, nominating novel drug targets for neurodegenerative disease using multi-omic and geneti….
0
17
0
@SingletonNeuro
Andrew
2 years
RT @ASAP_Research: Funding opportunity! GP2 is co-funding two places for @movedisorder Aspen Course. If you are an early career Movement Di….
0
2
0
@SingletonNeuro
Andrew
2 years
RT @FromTheLabBench: I wrote a blog post for International Women's Day, featuring women in #datascience and #neuroscience at @NIHAging's Ce….
0
5
0
@SingletonNeuro
Andrew
2 years
RT @ASAP_Research: 🎉In case you missed it📢. BLAAC-PD is expanding to six sites, allowing the initiative to continue to grow its partnership….
0
1
0
@SingletonNeuro
Andrew
2 years
RT @ASAP_Research: If you are a doctor or scientist based in Africa, Asia or Latin America interested in getting a master's in clinical neu….
0
10
0
@SingletonNeuro
Andrew
2 years
V Excited about this. Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD
0
1
3
@SingletonNeuro
Andrew
2 years
RT @sarabandres1: 📢 Apply to get trained in data science while working with a ton of talented and motivated scientists on Alzheimer’s and r….
0
1
0
@SingletonNeuro
Andrew
3 years
A nice thread here:.
@PTenigma
Paul Thompson
3 years
BREAKING NEWS: New #Alzheimer drug #Lecanemab slows cognitive decline (18-month change in CDR-SB) by 27%, drastically lowers brain amyloid load by 59 centiloids to 23 (below PET amyloid positivity)! NEJM paper: #CTAD
Tweet media one
0
2
7
@SingletonNeuro
Andrew
3 years
It’s quafftide somewhere. Here in fact.
@susie_dent
Susie Dent
3 years
Word of the day is ‘quafftide’(16th century): a one-word announcement that it’s time for a drink.
0
0
2
@SingletonNeuro
Andrew
3 years
RT @mike_nalls: @ASAP_Research says GP2 release 3 is now official. Shout outs to the team for sharing > 14K samp….
0
6
0
@SingletonNeuro
Andrew
3 years
a fantastic resource. really excited to support this work through CARD at the NIH IRP. Next comes the exciting part. .
@Michael_E_Ward_
M W
3 years
New batch of engineered iPSC lines from JAX/iNDI, including much-requested APOE variants! Isogenic sets of APOE2, 3, 4, and Christchurch variants, plus revertant controls, all deeply QC'd and available with a clickable online MTA.
Tweet media one
0
0
5
@SingletonNeuro
Andrew
3 years
RT @mike_nalls: Anyone dug around in their GP2 tier2 buckets lately? If so, how's new data in release 3 (its live already in your workspace….
0
4
0